Accentus Medical is pleased to report the publication in a leading peer review orthopaedic journal of the case-control study demonstrating significant infection rate reduction in high-risk patients receiving Agluna® treated custom limb salvage devices.
Accentus Medical is pleased to announce the launch of its manufacturing capability for commercial supply of Agluna® anti-microbial surface technology for titanium medical implants.
Accentus Medical is pleased to announce the results of a retrospective review of near-term post-operative infection rates associated with orthopaedic limb salvage devices treated with its innovative Agluna® surface technology.
Accentus Medical has announced today the successful completion of a management buyout.
Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of Brian Howlett and Laurie Rostron to its board of directors.